JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$2.01B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.93B |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$1.27B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$920M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$909M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.06B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$2.61B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.47B |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.26B |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$990M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.29% |
| 2 | Technology | 12.89% |
| 3 | Financials | 12.24% |
| 4 | Healthcare | 8.95% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3951
Nokia
NOK
$58.1B
| $560K | ﹤0.01% |
110,675
-4,074
| -4% | -$21K |
2013 Q2
25 quarters
|
|
3952
iShares Global Healthcare ETF
IXJ
$4.25B
| $559K | ﹤0.01% |
9,161
-439,634
| -98% | -$26.9M |
2014 Q4
19 quarters
|
|
3953
NVE Corp
NVEC
$536M
| $559K | ﹤0.01% |
8,417
+2,594
| +45% | +$177K |
2017 Q4
7 quarters
|
|
|
PFBI
3954
DELISTED
Premier Financial Bancorp
PFBI
| $559K | ﹤0.01% |
32,560
-12,976
| -28% | -$206K |
2016 Q2
13 quarters
|
|
3955
WisdomTree True Developed International Fund
DOL
$817M
| $557K | ﹤0.01% |
12,117
-196
| -2% | -$8.98K |
2013 Q2
25 quarters
|
|
3956
Cohen & Steers Duration Preferred & Income Fund
LDP
$564M
| $556K | ﹤0.01% |
21,737
+2,442
| +13% | +$61.6K |
2017 Q2
9 quarters
|
|
3957
Kratos Defense & Security Solutions
KTOS
$8.04B
| $552K | ﹤0.01% |
29,723
+4,792
| +19% | +$101K |
2017 Q3
8 quarters
|
|
3958
Riverview Bancorp
RVSB
$120M
| $552K | ﹤0.01% |
74,901
+7,160
| +11% | +$55.6K |
2016 Q3
12 quarters
|
|
3959
Hudbay
HBM
$11.6B
| $551K | ﹤0.01% |
+152,506
| New | +$621K |
2019 Q3
0 quarters
|
|
3960
iRadimed
IRMD
$1.09B
| $550K | ﹤0.01% |
26,174
+9,378
| +56% | +$191K |
2016 Q3
12 quarters
|
|
3961
PRA Group
PRAA
$710M
| $546K | ﹤0.01% |
16,170
+2,044
| +14% | +$65.1K |
2013 Q2
25 quarters
|
|
3962
Rayonier Advanced Materials
RYAM
$497M
| $546K | ﹤0.01% |
126,319
+20,367
| +19% | +$87K |
2015 Q3
16 quarters
|
|
|
BFX
3963
DELISTED
BowFlex Inc.
BFX
| $545K | ﹤0.01% |
403,702
+73,087
| +22% | +$115K |
2013 Q2
25 quarters
|
|
|
USAK
3964
DELISTED
USA Truck Inc
USAK
| $544K | ﹤0.01% |
67,785
+61,990
| +1,070% | +$545K |
2017 Q3
8 quarters
|
|
|
AKCA
3965
PUT
DELISTED
Akcea Therapeutics Inc
AKCA
| $543K | ﹤0.01% |
35,300
-2,500
| -7% | -$53.3K |
2018 Q2
5 quarters
|
|
3966
Cavco Industries
CVCO
$4.44B
| $542K | ﹤0.01% |
2,824
-29,590
| -91% | -$5.24M |
2015 Q4
15 quarters
|
|
3967
Natural Health Trends
NHTC
$8.66M
| $542K | ﹤0.01% |
76,522
+24,233
| +46% | +$178K |
2017 Q4
7 quarters
|
|
3968
Champion Homes
SKY
$4.75B
| $541K | ﹤0.01% |
17,972
-7,882
| -30% | -$228K |
2016 Q4
11 quarters
|
|
|
CMRX
3969
DELISTED
Chimerix, Inc.
CMRX
| $541K | ﹤0.01% |
230,189
+214,626
| +1,379% | +$620K |
2013 Q2
25 quarters
|
|
3970
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$980M
| $540K | ﹤0.01% |
3,878
-10,392
| -73% | -$1.77M |
2018 Q3
4 quarters
|
|
|
SYBX
3971
DELISTED
Synlogic
SYBX
| $539K | ﹤0.01% |
15,665
+809
| +5% | +$58.5K |
2018 Q2
5 quarters
|
|
3972
Expro Ltd
XPRO
$1.83B
| $537K | ﹤0.01% |
18,832
+13,951
| +286% | +$425K |
2017 Q4
7 quarters
|
|
3973
MACOM Technology Solutions
MTSI
$23B
| $535K | ﹤0.01% |
24,911
+1,261
| +5% | +$24.6K |
2014 Q1
22 quarters
|
|
|
INOV
3974
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $535K | ﹤0.01% |
32,642
-28,041
| -46% | -$448K |
2017 Q4
7 quarters
|
|
3975
Bloom Energy
BE
$81.8B
| $532K | ﹤0.01% |
163,567
-674,318
| -80% | -$5.04M |
2018 Q3
4 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2019 Portfolio in Review
As of Q3 2019, JP Morgan Chase held 6,188 positions worth $502B, down 1.8% from $511B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q3 2019 filing shows 385 new, 2,786 increased, 1,863 reduced and 426 closed positions. Its largest new stake was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.06B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q3 2019 buy was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M.
- JP Morgan Chase added most to iShares 7-10 Year Treasury Bond ETF in Q3 2019, an estimated $2.01B increase.
- JP Morgan Chase's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.06B.
- JP Morgan Chase fully exited Worldpay, Inc. in Q3 2019, selling an estimated $372M.
- JP Morgan Chase's ten largest holdings make up 16% of its $502B portfolio in Q3 2019.
- JP Morgan Chase opened 385 new positions and closed 426 in Q3 2019.
- JP Morgan Chase's portfolio value fell 1.8% quarter-over-quarter to $502B.
Based on JP Morgan Chase's 13F filing for Q3 2019, filed 12 Nov 2019.